Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study.

[1]  K. Lunetta,et al.  Relations of Inflammatory Biomarkers and Common Genetic Variants With Arterial Stiffness and Wave Reflection , 2008, Hypertension.

[2]  L. Badimón,et al.  Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction , 2008 .

[3]  L. Badimón,et al.  Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction. , 2008, Atherosclerosis.

[4]  K. Lunetta,et al.  Genome-wide association with select biomarker traits in the Framingham Heart Study , 2007, BMC Medical Genetics.

[5]  C. DeCarli,et al.  Inflammatory biomarkers are associated with total brain volume , 2007, Neurology.

[6]  Jonathan D. Smith,et al.  Letter to the Editor Decreased Atherosclerosis in Mice Deficient in Tumor Necrosis Factor-α Receptor-II (p75) , 2007 .

[7]  G. Lowe,et al.  Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. , 2007, European heart journal.

[8]  P. Ridker,et al.  Comparison of Interleukin-6 and C-Reactive Protein for the Risk of Developing Hypertension in Women , 2007, Hypertension.

[9]  M. Siemionow,et al.  Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo. , 2007, Blood.

[10]  Jonathan D. Smith,et al.  Decreased atherosclerosis in mice deficient in tumor necrosis factor-alpha receptor-II (p75). , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[11]  M. Siemionow,et al.  TNF-α receptor-II is required for TNF-α- induced leukocyte-endothelial interaction in vivo , 2006 .

[12]  G. Lowe,et al.  Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. , 2006, American journal of epidemiology.

[13]  V. Salomaa,et al.  C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality , 2006, Thrombosis and Haemostasis.

[14]  R. Talamini,et al.  Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease , 2006, Journal of Clinical Pathology.

[15]  A. Newman,et al.  Mortality and Cardiovascular Risk Across the Ankle-Arm Index Spectrum: Results From the Cardiovascular Health Study , 2006, Circulation.

[16]  A. Khera,et al.  Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study , 2005, Circulation.

[17]  E. Boerwinkle,et al.  Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. , 2005, Atherosclerosis.

[18]  P. Ridker,et al.  Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). , 2005, The American journal of cardiology.

[19]  Ioanna Tzoulaki,et al.  C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study , 2005, Circulation.

[20]  S. Bandinelli,et al.  Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. , 2005, American heart journal.

[21]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.

[22]  Richard B Devereux,et al.  Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.

[23]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[24]  Daniel Levy,et al.  The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. , 2003, Archives of internal medicine.

[25]  P. Ridker,et al.  Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. , 2003, The American journal of cardiology.

[26]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[27]  G. Malaponte,et al.  High circulating levels of cytokines (IL-6 and TNFa), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test , 2003, Vascular medicine.

[28]  A. Hofman,et al.  C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree: The Rotterdam Study , 2002, Stroke.

[29]  J. Murabito,et al.  Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. , 2002, American heart journal.

[30]  J. Pankow,et al.  Association of C-reactive protein with markers of prevalent atherosclerotic disease. , 2001, The American journal of cardiology.

[31]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[32]  B. Fagerberg,et al.  Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. , 2001, Clinical science.

[33]  N. Fiotti,et al.  Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. , 1999, Atherosclerosis.

[34]  Jianglin Fan,et al.  Atherosclerosis and inflammation: Mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis , 1998 .

[35]  P. Ridker,et al.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.

[36]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.